Miguel Ángel Muñoz-Alía

Author

Mayo Clinic ORCID

Also Known As

Miguel Angel Muñoz-Alía, Miguel Muñoz-Alía, Miguel Á. Muñoz-Alía, Miguel Ángel Muñoz-Alía

Publications

684

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed Joint Center for Structural Genomics Duke University

MÁ

About

Miguel Ángel Muñoz-Alía is an author at Mayo Clinic specializing in virology, vaccination, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	90
2	Immunology	4	4	68
3	Epidemiology	1	1	22
4	Pathology	1	1	23
5	Humoral Immunity	1	1	18

Miguel Ángel Muñoz-Alía

Publications

488

Citations

H-Index

Page 1

	Year	Citations
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones, Science	2021	246
Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Lianwen Zhang, Cell Reports Medicine	2021	52
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i> Nir Drayman, Krysten A. Jones, Saara‐Anne Azizi,	2020	41
Antigenic Drift Defines a New D4 Subgenotype of Measles Virus Miguel Ángel Muñoz-Alía, Claude P. Muller, Stephen J. Russell Journal of Virology	2017	23
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune Patients Eugene S. Bah, Rebecca A. Nace, Kah Whye Peng, Molecular Cancer Therapeutics ImmunologyViral PathogenesisPathologyImmunoeditingMeasles Immune Patients	2020	23
Measles virus genetic evolution throughout an imported epidemic outbreak in a highly vaccinated population Miguel Ángel Muñoz-Alía, Rafael Fernández-Muñoz, José M. Casasnovas, Virus Research VaccinationViral EvolutionVirus EpidemiologyImported Epidemic OutbreakViral Dynamic	2014	22
MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Alexander Tischer, PLoS Pathogens	2021	20
Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins Miguel Ángel Muñoz-Alía, Stephen J. Russell Viruses VaccinationVirus StructureMolecular VirologyLive Virus ChallengeViral Diagnostics	2019	18
Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses Miguel Ángel Muñoz-Alía, Claude P. Muller, Stephen J. Russell PLoS ONE	2018	16
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine Kah-Whye Peng, Timothy S. Carey, Patrycja Lech, Vaccine VaccinationSars-cov-2 ImmunityVaccine DevelopmentVaccine TargetImmunology	2022	14

Page 1